Compare Virgin Galactic Holdings, Inc. (SPCE) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Virgin Galactic Holdings, Inc. vs GeneDx Holdings Corp — how do they compare? Virgin Galactic Holdings, Inc. trades at $3.28 (market cap $498.02M), while GeneDx Holdings Corp trades at $81.63 (market cap $2.44B). The key difference: GeneDx Holdings Corp is far larger — about 4.9× Virgin Galactic Holdings, Inc.'s market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals.
| SPCE | WGS | |
|---|---|---|
Market Cap | $498.02M | $2.44B |
Sector | Industrials | Technology |
52-Week High | $7.52 | $167.51 |
52-Week Low | $2.17 | $34.51 |
Enterprise Value | $597.87M | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Virgin Galactic (SPCE) trades at $3.275, up 1.39% on the day, with a bullish technical signal from moving averages. The company continues to report significant losses, with a net income margin of -19,781.3% and negative cash flow from operations of $240.14M in 2025. Recent quarters have seen earnings beats against low expectations. Analyst sentiment is mixed, with a Buy/Hold/Sell split of 29.41%/41.18%/29.41% among 17 analysts.
The outlook remains highly speculative, driven by progress in commercial spaceflight operations against persistent financial losses. Investment opportunity hinges on successful scaling and future revenue generation, but risks include cash burn, high debt, and intense competition in the space sector. The stock is suitable only for risk-tolerant investors betting on long-term commercialization.
GeneDx Holdings Corp (WGS) trades at $82.36, up 5.75% in 24 hours, with a bullish technical signal and strong analyst support. Recent Q2 2026 results beat expectations with $0.01 EPS and record testing volumes, though net income margins remain negative. The stock faces class action litigation risks but benefits from institutional buying and new product launches.
Outlook is mixed: bullish technicals and 91% buy ratings suggest upside to the $90 high target, but negative profitability and legal overhangs pose risks. Investors should weigh growth potential against financial sustainability and litigation outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
